Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Boehringer launches new purification technology for Ingelvac CircoFLEX®
Drug firm Boehringer Ingelheim has announced new purification technology for Ingelvac CircoFLEX®.
Vaccine to be launched in all EU countries in January 2020

Pharmaceutical firm Boehringer Ingelheim has announced a new and proprietary purification process for its swine vaccine, Ingelvac CircoFLEX®.

Ingelvac CircoFLEX® was the first PCV2 (porcine circovirus type 2) that could be mixed with an M hyo vaccine to address two critical swine pathogens in a single dose. Considered to be the most revolutionary PCV2 vaccines on the market, it provides effective control of circovirus-associated disease in pigs aged three weeks and older.

The new diafiltration process, named DiaTEC, removes residual cell media components from the virus-like particles (VLPs) to obtain highly immunogenic and non-virucidal vaccine.

A press release reads: “With DiaTEC, a new and proprietary diafiltration technology, Ingelvac CircoFLEX® becomes the first and only non-virucidal PCV2 vaccine for improved capabilities to be freshly mixed on farm.”

Eva Joras, global brand manager at Boehringer Ingelheim, said: “I am really proud that we continuously invest in our research and development to further improve our leading products to address our customers’ needs.”

Ingelvac CircoFLEX®, manufactured with the new technology, will be launched in several different packaging sizes in all EU countries in January 2020. 

Become a member or log in to add this story to your CPD history

Kennel Club appoints new chief executive

News Story 1
 The Kennel Club has announced the appointment of Mark Beazley, who was previously Cats Protection's director of operations, as chief executive. Mark replaces Rosemary Smart, who stepped down from the role in April after 18 years.

Mark has held several senior strategic and executive roles, including executive director at Dogs Trust Ireland and chair of the Companion Animal Working Group at Eurogroup for Animals. He was also heavily involved in the establishment of the Eu Cat and Dog Alliance.

Mark will take up his new role in October. 

Click here for more...
News Shorts
International Cat Care appoints new head of veterinary division

International Cat Care (ICC) has announced the appointment of Nathalie Dowgray as head of the charity's veterinary division.

Nathalie, who is an RCVS advanced practitioner in feline medicine, will lead the International Society of Feline Medicine (ISFM) and a play key role in advancing knowledge and research in feline medicine.

Claire Bessant, iCatCare's chief executive said: "We're absolutely delighted to be welcoming Nathalie to the charity. She brings a depth and breadth of feline expertise and understanding which fits perfectly with the charity's work and development, and her enthusiasm for cats is infectious."